Figure 1. Hazard ratios (95% CIs) for the associations between animal foods and colorectal cancer in UK ... Participants are categorized according to their.

Slides:

Advertisements

Similar presentations

Figure 2. Number of cases required in a Mendelian randomization analysis with a binary outcome and a single instrumental variable for 80% power with a.

Advertisements

J Exp Bot. 2017;68(17): doi: /jxb/erx352

From: Learning by Working in Big Cities

From: Introducing the PRIDE Archive RESTful web services

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.

Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.

ADAb: anti-drug antibody.

Figure 1. Overview of the workflow of NetworkAnalyst 3.0.

FIGURE 1 Kidney biopsies of Patients 1 and 2

Figure 1 Hazard ratios as a function of annual mean PM2

Figure 1 The study area within Vienna Zoo is outlined in red

Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.

Figure 1 Data-selection process

FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.

FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels

Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.

FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:

FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.

FIGURE 1 Flow chart of patient enrollment and exclusion

Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.

Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.

Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.

Figure 1. Chemical structures of DNA and tc-DNA

bDMARD: biologic DMARD.

Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.

Fig. 1 Mean change from baseline in ANC ± s. e

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

Figure 1. Historical dialectic framework to assess transnational advocacy network influence Unless provided in the caption above, the following copyright.

FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).

Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.

Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.

Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.

Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.

Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.

FIGURE 1 Malta: a plate-style food guide

Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.

FIGURE 1 Study consort diagram

Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.

FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,

Figure 1. Results of search based on the PRISMA statement.14

Figure 1. Using Voronoi tessellation to define contacts

Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)

Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.

Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.

Figure 1 Ratio of the geometric mean concentration of hsTnT (A) and sST2 (B) at baseline (BL) and each subsequent ... Figure 1 Ratio of the geometric mean.

Figure 1. Ratios of simulated hazard rates of reporting for states with high trade exposure to those with low exposure, ... Figure 1. Ratios of simulated.

Figure 1. The configuration menu allows the user to choose among the main visualization/processing options of the ... Figure 1. The configuration menu.

Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.

Figure 1. The framework of NetGO with seven steps

Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.

Figure 1 Patient disposition

Figure 1. Trial profile. (A) Part A and (B) part B

Figure 1 Design of trials included in individual patient data meta-analysis. Unless provided in the caption above, the following copyright applies to the.

Figure 1 Distribution of WCD use days in WEARIT-II

Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.

Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.

Figure 1. The proportion of CSBM responders over the 2-week treatment period (A), the proportion of SBM responders by ... Figure 1. The proportion of CSBM.

Figure 1 Genetic results. No case had more than one diagnostic result

Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.

Estimates are from linear regression with robust ...

Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.

Source:Zimnisky (2014). Source:Zimnisky (2014).

Figure 1 Mechanisms of mitral regurgitation.

FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 1 Changes in lipids and lipoproteins.

Figure 2. Model adequacy results for the two empirical data sets, West African Ebola, and 2009 H1N1 influenza. The ... Figure 2. Model adequacy results.

Fig. 1. Examples of plots of NanoPlot and NanoComp

Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.

Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.

Presentation transcript:

Figure 1. Hazard ratios (95% CIs) for the associations between animal foods and colorectal cancer in UK ... Participants are categorized according to their intake at recruitment. Mean intake in each category is from the web-based 24-hour dietary assessments. Trend per increment uses the re-measured intakes from the web-based 24-hour dietary assessments. Models were stratified by age (<45, 45–, 50–, 55–, 60–, ≥65 years), sex, geographical region (10 regions) and socio-economic status (in fifths, based on the Townsend deprivation index<sup>14</sup>) and adjusted for education (College or University degree, vocational qualifications, optional national exams at ages 17–18 years, national exams at age 16 years, none of the above, unknown), smoking status (never, past, current <10 cigarettes per day, current 10–14 cigarettes per day, current 15–19 cigarettes per day, current 20+ cigarettes per day, unknown), waist circumference (sex-specific fifths, unknown), height (sex-specific fifths, unknown), physical activity [low: <10 excess metabolic equivalent (MET)-hours per week, moderate: 10–49.9 excess MET-hours per week, high: ≥50 excess MET-hours per week, unknown<sup>15</sup>], alcohol intake (<1, 1–7, 8–15, ≥16 g/day, unknown) (except for analyses where alcohol was the main exposure), family history of colorectal cancer (mother, father or sibling having had colorectal cancer, no family history, unknown), aspirin or ibuprofen use (regular use, not regular use, unknown), use of vitamin D supplements (regular use, not regular use, unknown), use of folate supplements (regular use, not regular use, unknown) and in women only: parity (0, 1–2, ≥3 live births, unknown), menopause (pre-menopausal, post-menopausal, unsure because of hysterectomy, unsure because of other reason, unknown), oral contraceptive agent (OCA) use (never, ever, unknown) and HRT use (never, ever, unknown). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Int J Epidemiol, dyz064, https://doi.org/10.1093/ije/dyz064 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. Hazard ratios (95% CIs) for the associations between plant foods, fibre, and alcohol and colorectal cancer in ... Participants are categorized according to their intake at recruitment. Mean intake in each category is from the web-based 24-hour dietary assessments. Trend per increment uses the re-measured intakes from the web-based 24-hour dietary assessments. Models were stratified by age (<45, 45–, 50–, 55–, 60–, ≥65 years), sex, geographical region (10 regions) and socio-economic status (in fifths, based on the Townsend deprivation index<sup>14</sup>) and adjusted for education (College or University degree, vocational qualifications, optional national exams at ages 17–18 years, national exams at age 16 years, none of the above, unknown), smoking status (never, past, current <10 cigarettes per day, current 10–14 cigarettes per day, current 15–19 cigarettes per day, current 20+ cigarettes per day, unknown), waist circumference (sex-specific fifths, unknown), height (sex-specific fifths, unknown), physical activity [low: <10 excess metabolic equivalent (MET)-hours per week, moderate: 10–49.9 excess MET-hours per week, high: ≥50 excess MET-hours per week, unknown<sup>15</sup>], alcohol intake (<1, 1–7, 8–15, ≥16 g/day, unknown) (except for analyses where alcohol was the main exposure), family history of colorectal cancer (mother, father or sibling having had colorectal cancer, no family history, unknown), aspirin or ibuprofen use (regular use, not regular use, unknown), use of vitamin D supplements (regular use, not regular use, unknown), use of folate supplements (regular use, not regular use, unknown) and in women only: parity (0, 1–2, ≥3 live births, unknown), menopause (pre-menopausal, post-menopausal, unsure because of hysterectomy, unsure because of other reason, unknown), oral contraceptive agent (OCA) use (never, ever, unknown) and HRT use (never, ever, unknown). Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the International Epidemiological Association.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Int J Epidemiol, dyz064, https://doi.org/10.1093/ije/dyz064 The content of this slide may be subject to copyright: please see the slide notes for details.